蛛网膜下腔出血后迟发性脑缺血患者的脑低灌注负担
OBJECTIVE: Delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) may result in focal neurological deficits and cerebral infarction, believed to result from critical regional rather than global impairments in cerebral blood flow (CBF).…
要点
- DCI患者低灌注负担更高,尽管整体CBF无显著差异。
- 低灌注负担预测DCI的AUC为0.71,优于整体CBF的0.65。
- 有局灶症状者症状侧半球低灌注负担有更高趋势(21% vs 18%,p=0.049)。
核心结论
- DCI患者低灌注负担更高,即使接受了血流动力学治疗、平均动脉压更高且整体CBF相当。
- 有局灶性缺损的DCI患者症状侧半球低灌注负担有更高趋势,而平均CBF与对侧相似。
- 评估临界低灌注的脑比例可能比平均CBF更好地反映DCI范围。
研究设计与样本
- 排除CT上可见异常脑区(出血和梗死区)。
- 低灌注负担定义为正常表现脑中CBF<25 ml/100 g/min的PET像素比例。
主要发现
- 23例(38%)在PET时存在临床DCI。
- DCI患者平均动脉压更高(126±14 vs 106±12 mm Hg,p<0.001),18例(78%)使用升压药。
- 整体CBF在DCI组与无DCI组无显著差异(39.4±11.2 vs 43.0±8.3 ml/100 g/min,p=0.16)。
- 低灌注负担在DCI组更高(20%,IQR 12%-23% vs 12%,9%-16%,p=0.006)。
- 低灌注负担预测DCI的AUC为0.71,整体CBF为0.65(p=0.044)。
关键数值与推荐
- 低灌注负担定义:正常表现脑中CBF<25 ml/100 g/min的PET像素比例。
- DCI组低灌注负担中位数20%(IQR 12%-23%),无DCI组12%(IQR 9%-16%),p=0.006。
- 13例有局灶性缺损者症状侧半球低灌注负担21% vs 对侧18%,p=0.049。
临床怎么用
- 对于SAH后DCI风险评估,可考虑评估低灌注脑比例而非仅依赖整体CBF。
- 症状侧半球低灌注负担更高提示局灶性低灌注可能解释神经功能缺损。
局限性
- 低灌注负担为影像学指标,需进一步验证其临床预测价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) may result in focal neurological deficits and cerebral infarction, believed to result from critical regional rather than global impairments in cerebral blood flow (CBF). However, the burden of such regional hypoperfusion has not been evaluated by gold-standard voxel-by-voxel CBF measurements. Specifically, the authors sought to determine whether the proportion of brain affected by hypoperfusion was greater in patients with DCI than in SAH controls without DCI and whether the symptomatic hemisphere (in those with lateralizing deficits) exhibited a greater cerebral hypoperfusion burden. METHODS: Sixty-one patients with aneurysmal SAH underwent 15O PET to measure regional CBF during the period of risk for DCI (median 8 days after SAH, IQR 7-10 days). Regions of visibly abnormal brain on head CT studies, including areas of hemorrhage and infarction, were excluded. Burden of hypoperfusion was defined as the proportion of PET voxels in normal-appearing brain with CBF < 25 ml/100 g/min. Global CBF and hypoperfusion burden were compared between patients with and those without DCI at the time of PET. For patients with focal impairments from DCI, the authors also compared average CBF and hypoperfusion burden in symptomatic versus asymptomatic hemispheres. RESULTS: Twenty-three patients (38%) had clinical DCI at the time of PET. Those with DCI had higher mean arterial pressure (MAP; 126 ± 14 vs 106 ± 12 mm Hg, p < 0.001) and 18 (78%) were on vasopressor therapy at the time of PET study. While global CBF was not significantly lower in patients with DCI (mean 39.4 ± 11.2 vs 43.0 ± 8.3 ml/100 g/min, p = 0.16), the burden of hypoperfusion was greater (20%, IQR 12%-23%, vs 12%, 9%-16%, p = 0.006). Burden of hypoperfusion performed better than global CBF as a predictor of DCI (area under the curve 0.71 vs 0.65, p = 0.044). Neither global CBF nor hypoperfusion burden differed in patients who responded to therapy compared to those who had not improved by the time of PET. Although hemispheric CBF was not lower in the symptomatic versus contralateral hemisphere in the 13 patients with focal deficits, there was a trend toward greater burden of hypoperfusion in the symptomatic hemisphere (21% vs 18%, p = 0.049). CONCLUSIONS: The burden of hypoperfusion was greater in patients with DCI, despite hemodynamic therapies, higher MAP, and equivalent global CBF. Similarly, hypoperfusion burden was greater in the symptomatic hemisphere of DCI patients with focal deficits even though the average CBF was similar to that in the contralateral hemisphere. Evaluating the proportion of the brain with critical hypoperfusion after SAH may better capture the extent of DCI than averaging CBF across heterogenous brain regions.
引用
- Jafri H, Diringer MN, Allen M, et al. Burden of cerebral hypoperfusion in patients with delayed cerebral ischemia after subarachnoid hemorrhage. J Neurosurg. 2019. PMID: 31151110. doi:10.3171/2019.3.JNS183041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。